1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
New Generation of Glucose Control Technologies Incorporating AI/ML is a funding announcement from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at NIH that will solicit applications for research to improve open- and closed-loop diabetes control systems for Type 1 diabetes.
Research priorities include innovations in analyte sensing, novel hormone formulation and delivery, AI and machine learning-driven algorithms, and digital twin modeling to enhance glycemic control and quality of life. Awards will use the R01 research project grant activity code. Applications are not yet being solicited but the notice was issued to allow potential applicants time to develop meaningful collaborations.
Eligible applicants include universities, nonprofits, Tribal governments, for-profit organizations, and federal agencies.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies Agency: National Institutes of Health Assistance Listings: 93. 847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research Last Updated: June 18, 2025 View version history on Grants.
gov The NIDDK, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research to overcome barriers that limit progress toward more effective open- and closed-loop diabetes control systems.
This may include research that addresses: 1) innovation of sensing relevant analytes/physiologic signals; 2) novel formulation and delivery of hormones; 3) artificial intelligence (AI)/machine learning (ML)-driven tools/algorithms; and 4) digital twin modeling to augment decision support and automated control systems with the goal of improving glycemic control, reducing burden of care, and enhancing quality of life of people with T1D.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R01-research project grant activity code.
Investigators with expertise and insights into this area of science and technology development are encouraged to begin to consider applying for this new NOFO.
In addition, collaborative investigations combining expertise in endocrine physiology, behavioral science and interventions, data science, artificial intelligence, machine learning and smart/adaptable algorithms, digital twins, decision support systems, precision and personalized medicine, design of mobile/ wearable devices sensing multiple analytes, hormone formulation and delivery by closed loop systems, in silico modeling, preclinical and clinical testing will be encouraged and these investigators should also begin considering applying for this application.
Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Independent school districts Private institutions of higher education Public and state institutions of higher education Public and Indian housing authorities Federally recognized Native American tribal governments For-profit organizations other than small businesses Indian/Native American Tribal Governments (Other than Federally Recognized); Eligible Agencies of the Federal Government; U.S. Territory or Possession; Faith-based or Community-based Organizations; Regional Organizations Non-domestic (non-U.S.) Entities (Foreign Institutions) Grantor contact information No documents are currently available.
Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity :
According to the current listing, eligibility includes: Higher ed, nonprofits, small businesses, etc. Confirm the full requirements in the official notice before applying.
The published deadline was June 18, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
New Generation of Glucose Control Technologies Incorporating AI/ML is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
NIH's FY2026 budget held steady at $47.2 billion — yet by the end of February the agency had issued roughly 66% fewer competitive grant awards than its FY21–24 average, and by late spring award volume was still running dramatically below historical norms. The cause is not a budget cut. It is a pipeline failure: only 14 Notices of Funding Opportunity published by mid-March versus 756 in all of 2024, a workforce down nearly 20%, funds held by OMB into March, and new political-appointee sign-off on NOFOs. FY25 success rates fell to 17% — the lowest in 30 years — and early-stage investigators dropped to 18.5%. This is the definitive breakdown of what is happening, why the money isn't moving, and the concrete diversification strategy labs need for the next 18 months.
Read articleAfter an authorization lapse froze new SBIR/STTR awards for five months, NIH reopens its submission window on August 5, 2026, with a first standard deadline of September 8. Phase I awards run to $323,090, Phase II to $2,153,927, with published waiver topics reaching $700,000 and $3 million — and a new Phase IIB Strategic Breakthrough lane up to $30 million. Here is how the restarted omnibus is structured, why applying early matters more than usual this cycle, and how to position a life-science startup to win.
Read articleNIH has awarded 74% fewer new grants than its 2021-2024 average and is roughly $1 billion behind its normal timeline, but the FY2026 money still has to go out the door before the fiscal year ends. Here is why a year-end obligation cliff is coming, who is positioned to catch it, and how applicants should prepare for a compressed Q4 award rush.
Read article